Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

JLK inhibitors: isocoumarin compounds as putative probes to selectively target the gamma-secretase pathway.

Checler F, Frédéric C, Alves da Costa C, Cristine Ada C, Ayral E, Erwan A, Andrau D, David A, Dumanchin C, Cécile D, Farzan M, Michael F, Hernandez JF, Jean-François H, Martinez J, Lefranc-Jullien S, Solveig LJ, Marambaud P, Philippe M, Pasini A, Andrea P, Petit A, Agnès P, Phiel C, Christopher P, Robert P, Philippe R, St George-Hyslop P, Peter SG, Wilk S, Sherwin W. JLK inhibitors: isocoumarin compounds as putative probes to selectively target the gamma-secretase pathway. Curr Alzheimer Res. 2005 Jul; 2(3):327-34.

View in: PubMed

collapse authors with profiles


Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)